Evaluation of olfactory dysfunction in neurodegenerative diseases
- PMID: 23010543
- DOI: 10.1016/j.jns.2012.08.028
Evaluation of olfactory dysfunction in neurodegenerative diseases
Abstract
It is known that the olfactory dysfunction is involved in various neurological diseases, such as Parkinson's disease, Alzheimer's disease, multiple sclerosis, Huntington's disease and motor neuron disease. In particular, the ability to identify and discriminate the odors, as well as the odor threshold, can be altered in these disorders. These changes often occur as early manifestation of the pathology and they are not always diagnosed on time. The aim of this review is to summarize the major neurological diseases which are preceded or accompanied by olfactory dysfunction. In addition, new instrumental approaches, such as psychophysical testing, olfactory event-related potentials (OERPs) and functional magnetic resonance imaging (fMRI) measurements, supported by olfactometer for the stimuli delivery, and their combination in evaluation of olfactory function will be discussed. In particular, OERPs and fMRI might to be good candidates to become useful additional tools in clinical protocols for early diagnosis of neurological diseases.
Copyright © 2012 Elsevier B.V. All rights reserved.
Similar articles
-
[Changes in olfaction during ageing and in certain neurodegenerative diseases: up-to-date].Rev Med Interne. 2015 Jan;36(1):31-7. doi: 10.1016/j.revmed.2014.09.008. Epub 2014 Oct 7. Rev Med Interne. 2015. PMID: 25304170 Review. French.
-
[Olfaction and neurological diseases: a review of the literature].Rev Neurol (Paris). 2007 Feb;163(2):155-67. doi: 10.1016/s0035-3787(07)90387-2. Rev Neurol (Paris). 2007. PMID: 17351535 Review. French.
-
Olfactory function in mild cognitive impairment and Alzheimer's disease: an investigation using psychophysical and electrophysiological techniques.Am J Psychiatry. 2003 Nov;160(11):1995-2002. doi: 10.1176/appi.ajp.160.11.1995. Am J Psychiatry. 2003. PMID: 14594747
-
The course of olfactory deficits in patients with Parkinson's disease--a study based on psychophysical and electrophysiological measures.Neurosci Lett. 2010 Dec 17;486(3):166-70. doi: 10.1016/j.neulet.2010.09.044. Epub 2010 Sep 19. Neurosci Lett. 2010. PMID: 20858529
-
[Diagnosis of olfactory disorders--clinical standards and research].Laryngorhinootologie. 2007 Aug;86(8):565-72. doi: 10.1055/s-2007-966532. Laryngorhinootologie. 2007. PMID: 17665356 Review. German.
Cited by
-
Odor Identification Across Time in Mutation Carriers and Non-Carriers in Autosomal-Dominant Alzheimer's Disease.J Alzheimers Dis. 2024;97(2):587-598. doi: 10.3233/JAD-230618. J Alzheimers Dis. 2024. PMID: 38160354 Free PMC article.
-
SNAP25 is a potential target for early stage Alzheimer's disease and Parkinson's disease.Eur J Med Res. 2023 Dec 6;28(1):570. doi: 10.1186/s40001-023-01360-8. Eur J Med Res. 2023. PMID: 38053192 Free PMC article.
-
Understanding the spectrum of non-motor symptoms in multiple sclerosis: insights from animal models.Neural Regen Res. 2024 Jan;19(1):84-91. doi: 10.4103/1673-5374.375307. Neural Regen Res. 2024. PMID: 37488849 Free PMC article. Review.
-
Knockout of angiotensin converting enzyme-2 receptor leads to morphological aberrations in rodent olfactory centers and dysfunctions associated with sense of smell.Front Neurosci. 2023 Jun 19;17:1180868. doi: 10.3389/fnins.2023.1180868. eCollection 2023. Front Neurosci. 2023. PMID: 37404465 Free PMC article.
-
Amelioration of Cognitive and Olfactory System Deficits in APOE4 Transgenic Mice with DHA Treatment.Mol Neurobiol. 2023 Oct;60(10):5624-5641. doi: 10.1007/s12035-023-03401-z. Epub 2023 Jun 17. Mol Neurobiol. 2023. PMID: 37329383
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
